Clinical Characteristics of Patients With Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin

JAMA Neurology - United States
doi 10.1001/jamaneurol.2016.2032
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

American Medical Association (AMA)

Related search

Infantile Onset Myasthenia Gravis With MuSK Antibodies

Pediatric Neurology Briefs
2006English

Clinical Features and Quality of Life in Patients With Myasthenia Gravis

Journal of the Neurological Sciences
Neurology
2015English

Circulating Regulatory Anti–T Cell Receptor Antibodies in Patients With Myasthenia Gravis

Journal of Clinical Investigation
Medicine
2003English

Association of Ramadan Fasting and Clinical Outcomes in Patients With Myasthenia Gravis

JAMA network open
Medicine
2020English

Anti-P110 Autoantibodies Identify a Subtype of “Seronegative” Myasthenia Gravis With Prominent Oculobulbar Involvement

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2002English

The Relationship of Plasma Levels of Pyridostigmine to Clinical Effect in Patients With Myasthenia Gravis

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1981English

Antibodies to Striated Muscle and Acetylcholine Receptors in Evaluation of Surgical Treatment Outcomes in Patients With Autoimmune Myasthenia Gravis

Grekov's Bulletin of Surgery
2017English

Adverse Events Releated to Antibiotic Use in Patients With Myasthenia Gravis

Open Forum Infectious Diseases
OncologyNeurology
2017English

Myasthenia Gravis

CMAJ
Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy